Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 50K | Jun 13, 2024 | Direct | ||
MANNKIND CORP | Director | Restricted Stock Unit | 35K | May 15, 2024 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | By Trust | |
Horizon Therapeutics Public Ltd Co | Director | Ordinary Shares | 0 | $116.50 | Oct 6, 2023 | Direct | |
Horizon Therapeutics Public Ltd Co | Director | Restricted Stock Units | 0 | Oct 6, 2023 | Direct | ||
Horizon Therapeutics Public Ltd Co | Director | Stock Option (Right to Buy) | 0 | Oct 6, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XLO | Xilio Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
XLO | Xilio Therapeutics, Inc. | Jun 13, 2024 | 0 | $0 | 3 | Jun 17, 2024 | Director |
MNKD | MANNKIND CORP | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
HZNP | Horizon Therapeutics Public Ltd Co | Oct 6, 2023 | 5 | -$6.62M | 4 | Oct 6, 2023 | Director |
HZNP | Horizon Therapeutics Public Ltd Co | Sep 29, 2023 | 2 | $144K | 4 | Oct 2, 2023 | Director |
HZNP | Horizon Therapeutics Public Ltd Co | Jul 27, 2023 | 1 | $0 | 4 | Jul 28, 2023 | Director |
MNKD | MANNKIND CORP | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
HZNP | Horizon Therapeutics Public Ltd Co | Apr 28, 2023 | 3 | -$209K | 4 | May 2, 2023 | Director |
MNKD | MANNKIND CORP | May 10, 2022 | 1 | $0 | 4 | May 12, 2022 | Director |
HZNP | Horizon Therapeutics Public Ltd Co | Apr 28, 2022 | 4 | -$163K | 4 | May 2, 2022 | Director |
MNKD | MANNKIND CORP | May 20, 2021 | 2 | $0 | 4 | May 20, 2021 | Director |